330 related articles for article (PubMed ID: 10028020)
1. Differential activities of immunogenic collagen type II peptides in the induction of nasal tolerance to collagen-induced arthritis.
Chu CQ; Londei M
J Autoimmun; 1999 Feb; 12(1):35-42. PubMed ID: 10028020
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a peptide analog of a determinant of type II collagen that suppresses collagen-induced arthritis.
Myers LK; Tang B; Rosloniec EF; Stuart JM; Chiang TM; Kang AH
J Immunol; 1998 Oct; 161(7):3589-95. PubMed ID: 9759881
[TBL] [Abstract][Full Text] [Related]
3. Type II collagen in cartilage evokes peptide-specific tolerance and skews the immune response.
Malmström V; Kjellén P; Holmdahl R
J Autoimmun; 1998 Jun; 11(3):213-21. PubMed ID: 9693969
[TBL] [Abstract][Full Text] [Related]
4. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
[TBL] [Abstract][Full Text] [Related]
5. T cell epitopes of type II collagen that regulate murine collagen-induced arthritis.
Myers LK; Seyer JM; Stuart JM; Terato K; David CS; Kang AH
J Immunol; 1993 Jul; 151(1):500-5. PubMed ID: 7686947
[TBL] [Abstract][Full Text] [Related]
6. Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen.
Min SY; Hwang SY; Park KS; Lee JS; Lee KE; Kim KW; Jung YO; Koh HJ; Do JH; Kim H; Kim HY
Arthritis Res Ther; 2004; 6(3):R213-9. PubMed ID: 15142267
[TBL] [Abstract][Full Text] [Related]
7. Suppression of collagen-induced arthritis by oral or nasal administration of type II collagen.
Garcia G; Komagata Y; Slavin AJ; Maron R; Weiner HL
J Autoimmun; 1999 Nov; 13(3):315-24. PubMed ID: 10550219
[TBL] [Abstract][Full Text] [Related]
8. Vaccination with an immunodominant peptide of bovine type II collagen induces an anti-TCR response, and modulates the onset and severity of collagen-induced arthritis.
Honda A; Ametani A; Matsumoto T; Iwaya A; Kano H; Hachimura S; Ohkawa K; Kaminogawa S; Suzuki K; Sercarz EE; Kumar V
Int Immunol; 2004 May; 16(5):737-45. PubMed ID: 15096482
[TBL] [Abstract][Full Text] [Related]
9. Immunogenetics of collagen-induced arthritis in rats. Both MHC and non-MHC gene products determine the epitope specificity of immune response to bovine and chick type II collagens.
Griffiths MM; Cremer MA; Harper DS; McCall S; Cannon GW
J Immunol; 1992 Jul; 149(1):309-16. PubMed ID: 1376750
[TBL] [Abstract][Full Text] [Related]
10. Peptide-induced suppression of collagen-induced arthritis in HLA-DR1 transgenic mice.
Myers LK; Sakurai Y; Tang B; He X; Rosloniec EF; Stuart JM; Kang AH
Arthritis Rheum; 2002 Dec; 46(12):3369-77. PubMed ID: 12483744
[TBL] [Abstract][Full Text] [Related]
11. The influence of HLA-DR4 (0401) on the immune response to type II collagen and the development of collagen induced arthritis in mice.
Wang D; Hill JA; Cairns E; Bell DA
J Autoimmun; 2002 Mar; 18(2):95-103. PubMed ID: 11908942
[TBL] [Abstract][Full Text] [Related]
12. Induction of Th2 cytokines and control of collagen-induced arthritis by nondepleting anti-CD4 Abs.
Chu CQ; Londei M
J Immunol; 1996 Sep; 157(6):2685-9. PubMed ID: 8805674
[TBL] [Abstract][Full Text] [Related]
13. Potent adjuvant effect by anti-CD40 in collagen-induced arthritis. Enhanced disease is accompanied by increased production of collagen type-II reactive IgG2a and IFN-gamma.
Tellander AC; Michaëlsson E; Brunmark C; Andersson M
J Autoimmun; 2000 Jun; 14(4):295-302. PubMed ID: 10882055
[TBL] [Abstract][Full Text] [Related]
14. Comparison of nasal and oral tolerance for the prevention of collagen induced murine arthritis.
Higuchi K; Kweon MN; Fujihashi K; McGhee JR; Kiyono H
J Rheumatol; 2000 Apr; 27(4):1038-44. PubMed ID: 10782834
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of deer antler aqua-acupuncture, the pilose antler of Cervus Korean TEMMINCK var mantchuricus Swinhoe, on type II collagen-induced arthritis in rats.
Kim YK; Kim KS; Chung KH; Kim JG; Kim KS; Lee YC; Chang YC; Kim CH
Int Immunopharmacol; 2003 Jul; 3(7):1001-10. PubMed ID: 12810357
[TBL] [Abstract][Full Text] [Related]
16. Tumour necrosis factor receptor gene therapy affects cellular immune responses in collagen induced arthritis in mice.
Mukherjee P; Yang SY; Wu B; Song Z; Myers LK; Robbins PD; Wooley PH
Ann Rheum Dis; 2005 Nov; 64(11):1550-6. PubMed ID: 15860512
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of Th1-mediated pathology in experimental arthritis by stimulation of the Th2 arm of the immune response.
Mauri C; Feldmann M; Williams RO
Arthritis Rheum; 2003 Mar; 48(3):839-45. PubMed ID: 12632440
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the T cell determinants in the induction of autoimmune arthritis by bovine alpha 1(II)-CB11 in H-2q mice.
Brand DD; Myers LK; Terato K; Whittington KB; Stuart JM; Kang AH; Rosloniec EF
J Immunol; 1994 Mar; 152(6):3088-97. PubMed ID: 7511638
[TBL] [Abstract][Full Text] [Related]
19. Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184-198 of bovine type II collagen (CII) expressing a dominant T cell epitope.
Staines NA; Harper N; Ward FJ; Malmström V; Holmdahl R; Bansal S
Clin Exp Immunol; 1996 Mar; 103(3):368-75. PubMed ID: 8608633
[TBL] [Abstract][Full Text] [Related]
20. Treatment of experimental autoimmune arthritis by nasal administration of a type II collagen-cholera toxoid conjugate vaccine.
Tarkowski A; Sun JB; Holmdahl R; Holmgren J; Czerkinsky C
Arthritis Rheum; 1999 Aug; 42(8):1628-34. PubMed ID: 10446861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
